AstraZeneca: Psychotic Disorders trials
The registry lists 14 Psychotic Disorders studies with AstraZeneca as lead sponsor. 0 are open to participants now and 3 have results posted.
Phase 3 7Phase 4 2No phase 5(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Schizophrenic Patients in Integrated CareTerminatedNCT00681629Phase 4Results posted
- Study in Schizophrenic In-patients Treated With Quetiapine Prolong or Oral Risperidone at Flexible DoseTerminatedNCT00660595Phase 3Results posted
- A Study of the Cataractogenic Potential of Seroquel and Risperdal in the Treatment of Participants With Schizophrenia or Schizoaffective DisorderCompletedNCT00206102Phase 4Results posted
- Observational Study to Evaluate Bipolar Disorder Symptoms in Patients Presented With Schizophrenia or DepressionCompletedNCT01028196
- Validity of the Spanish Version of Subjective Well-being Under Neuroleptics Scale (SWN-K) in Patients With SchizophreniaCompletedNCT00749970
- Adherence in Adolescents and Children Treated on QuetiapineCompletedNCT00680888
- Schizophrenic Patients Taking Part in Integrated Care ProgramTerminatedNCT00617214
- Seroquel Long-Term NIS for Schizophrenia PatientsCompletedNCT00523783
- FAST-A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute PsychosisTerminatedNCT00486798Phase 3
- Rapid Versus Conventional Titration of Quetiapine in Schizophrenia/Schizoaffective DisorderTerminatedNCT00457899Phase 3
- Dose Finding of Quetiapine Fumarate 200mg vs 400mg in First Episode PsychosisCompletedNCT00449397Phase 3
- Seroquel STACK Study in Schizophrenic or Schizoaffective SubjectsCompletedNCT00328978Phase 3
- Fast Titration Of Quetiapine Versus Currently Approved TitrationCompletedNCT00254813Phase 3
- CAFE Comparison of Atypicals in First Episode of PsychosisCompletedNCT00034892Phase 3